Novartis India Q2 Net up 16% at Rs 45.55 cr

Last Updated: Wednesday, October 30, 2013, 19:13

Drug firm Novartis India on Wednesday reported 15.78 percent rise in net profit to Rs 45.55 crore for the quarter ended September 30, on the back of a favourable ruling in a dispute that resulted in higher tax credit.

Novartis lifts profit forecast for second quarter in a row

Last Updated: Tuesday, October 22, 2013, 18:27

Swiss drugmaker Novartis raised its full-year sales and profit forecasts for a second quarter in a row on Tuesday, as it benefited from delays to a cheap, copycat competitor to one of its best-selling drugs, blood pressure pill Diovan.

Govt refutes Novartis' allegations on patents

Last Updated: Wednesday, August 28, 2013, 19:24

"You would appreciate that more than 80 percent of patents registered in India are attributed to non-Indians," Commerce Secretary S R Rao has said in a letter to Novartis AG CEO Joseph Jimenez.

Novartis lashes out at India for not respecting IPR

Last Updated: Sunday, August 18, 2013, 14:09

According to the company, which lost a patent case for its cancer drug Glivec, India needs to have fast track courts to deal with IPR disputes.

Novartis Q1 Net down 49% at Rs 14 crore

Last Updated: Wednesday, July 24, 2013, 20:12

Drug major Novartis India Wednesday said its net profit declined by 48.69 percent to Rs 13.8 crore for the first quarter ended June 30, 2013, on account of rupee depreciation and slowdown in sales due to notification of new drug policy.

Payout for ex head of Novartis is cut down after outcry

Last Updated: Wednesday, July 17, 2013, 17:48

A bonanza payout to the former chairman of Novartis has been cut back radically, the pharmaceutical group said on Wednesday, reporting also a fall in second quarter profit.

Novartis, BioE join hands for typhoid, paratyphoid vaccines

Last Updated: Monday, July 8, 2013, 14:06

Switzerland-based drug major Novartis Monday said it has entered into a development and licensing agreement with Biological E (BioE) for two vaccines against typhoid and paratyphoid fevers.

Novartis AG sells 1.42 stake in Indian arm for Rs 25 cr

Last Updated: Friday, June 28, 2013, 19:35

Drug firm Novartis India Friday said its parent Novartis AG has offloaded 1.42 percent stake in it through open market for a consideration of over Rs 25 crore to meet market regulator SEBI guidelines.

Novartis India Q4 net profit dips 26% at Rs 24 cr

Last Updated: Tuesday, May 14, 2013, 18:47

The company had posted a net profit of Rs 32.91 crore for the quarter ended March 31, 2012.

Novartis appoints Citigroup as broker for Indian co share sale

Last Updated: Thursday, May 9, 2013, 15:09

Drug major Novartis India Thursday said its Swiss promoter Novartis AG has appointed Citigroup Capital Markets as the broker for the proposed share sale to reduce stake in the Indian entity.

US 'concerned' over patent norms, innovation climate in India

Last Updated: Thursday, May 2, 2013, 16:07

Raising questions over innovation climate in India, the US has said the recent decision by India's Supreme Court to prohibit patent of Novartis' cancer drug Glivec could "preclude issuance of a patent" in the country.

Pharma giant Novartis working on H7N9 vaccine

Last Updated: Thursday, April 25, 2013, 22:23

Swiss pharmaceuticals giant Novartis is researching a vaccine for the H7N9 strain of bird flu, its chief executive said Thursday, amid fears that the disease could mutate into a form that spreads among people.